Wegovy® 1 mg is a once-weekly, single-dose injectable pen containing semaglutide, a GLP-1 receptor agonist used for chronic weight management in adults with obesity or overweight conditions who have at least one weight-related health condition. It is part of a gradual dose-escalation schedule designed to improve tolerability and help the body adjust before reaching higher maintenance doses.
This medication works by mimicking the natural GLP-1 hormone, which helps regulate appetite and food intake. It acts on brain receptors that control hunger, helping to reduce appetite, decrease food cravings, and increase feelings of fullness after meals. When combined with a reduced-calorie diet and regular physical activity, it supports sustained weight loss over time.
The single-dose pen is prefilled and designed for subcutaneous injection once weekly, with each pen used for one dose only and then safely discarded.
Wegovy is intended for long-term, medically supervised weight management, not for rapid or cosmetic weight loss.
Common side effects may include:
- Nausea
- Vomiting
- Diarrhea or constipation
- Abdominal pain or bloating
- Reduced appetite
Side effects are often more noticeable during dose increases as the body adapts to treatment.
Always use exactly as prescribed by a healthcare professional and follow proper injection guidance.
Reviews
There are no reviews yet.